Denovx, LLC
Chicago, IL
- UEI
- DDMLLCM3VAF8
- CAGE
- 6RYU1
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- Iitri Center, 3440 S Dearborn St 204 s, Chicago, IL 60616, USA
- Website
- denovx.com
- Founded
- 2011
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Mitegen, LLC | Ithaca, NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Ligo Analytics Inc. | Dallas, TX | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Biosensing Instrument Inc. | Tempe, AZ | 334516 Analytical Laboratory Instrument Manufacturing |
| Nectagen Inc. | Lawrence, KS | 325414 Biological Product (except Diagnostic) Manufacturing |
| Dotquant LLC | Shoreline, WA | — |
About the company
Denovx, LLC is a for-profit limited liability company registered in SAM.gov since 2012, specializing in surface science technologies and innovative platform products for scientific research, with a primary focus on improving protein crystallization and imaging techniques. The company develops advanced solutions that address critical challenges in structural biology, specifically targeting improvements in protein research methodologies through engineered surface modifications and microfluidic technologies.
Through its federal grant awards, Denovx has consistently received funding from civilian agencies, particularly the National Institute of General Medical Sciences (NIGMS) and the National Institute on Drug Abuse (NIDA), to develop cutting-edge technologies for protein research. The company has been awarded multiple Phase I and Phase II Small Business Innovation Research (SBIR) grants focused on advanced scientific methodologies, including improving cryogenic electron microscopy (cryo-EM) specimen quality, developing nucleation technologies for membrane protein crystallization, and creating microfluidic protein flow crystallization chips. These projects aim to enhance structural biology research by addressing challenges in protein crystal formation, improving imaging resolution, and developing innovative platforms for studying proteins related to substance use disorders and infectious diseases. Denovx collaborates with research institutions like Vanderbilt University and leverages advanced techniques such as synchrotron X-ray diffraction and specialized surface modification strategies to advance scientific understanding of protein structures and potential therapeutic applications.
Quick answers
Is Denovx, LLC registered in SAM.gov?
Yes. Denovx, LLC's SAM.gov registration is active through January 24, 2027.
What is Denovx, LLC's CAGE code?
Denovx, LLC's CAGE code is 6RYU1, and its Unique Entity ID (UEI) is DDMLLCM3VAF8.
What is Denovx, LLC's most recent federal award?
Denovx, LLC's most recent federal grant award is Improving cryo-EM specimen quality using surface science (R43GM156151), from National Institute of General Medical Sciences (NIH), on September 18, 2024.
On GovTribe
See Denovx, LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors